Pre-implantation Genetic testing is the diagnostic of genetic and chromosomal abnormalities of IVF embryos after removing cells from these embryos before they are transferred to the uterus, in order to ensure that children are born free of hereditary diseases.
The term PGD, pre-implantation genetic diagnosis, is often used to refer to any pre-implantation genetic testing performed on an embryo before embryo transfer. However, the terms PGD and PGS are different.

  • inDNA performs Prenatal Genetic Screening (PGS) by Next Generation Sequencing (NGS) on Ion-Torrent Platform.
  • NGS provides a new approach with potential advantages including reduced costs and enhanced precision. It allows parallel and customizable analysis of multiple embryos on one chip.


The advantages of PGS:-


  • Improves implantation rates
  • Reduces spontaneous abortion
  • Increases ongoing pregnancy rate
  • Enables single embryo transfers, decreasing the number of high-risk multiple pregnancies.